Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2025)

Zhengye Biotechnology Holding has reported Work In Process over the past 3 years, most recently at $2.5 million for Q4 2025.

  • Quarterly Work In Process fell 45.8% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 45.8% year-over-year, with the annual reading at $2.5 million for FY2025, 44.15% down from the prior year.
  • Work In Process was $2.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $4.6 million in the prior quarter.
  • Over five years, Work In Process peaked at $4.7 million in Q4 2023 and troughed at $2.5 million in Q4 2025.
  • The 3-year median for Work In Process is $4.6 million (2024), against an average of $3.9 million.
  • Year-over-year, Work In Process fell 1.31% in 2024 and then crashed 45.8% in 2025.
  • A 3-year view of Work In Process shows it stood at $4.7 million in 2023, then decreased by 1.31% to $4.6 million in 2024, then crashed by 45.8% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Work In Process are $2.5 million (Q4 2025), $4.6 million (Q4 2024), and $4.7 million (Q4 2023).